Pivotal bioVenture Partners

Pivotal bioVenture Partners is a $300 million life sciences venture capital fund. We invest in privately-held North American and European companies focused on innovative therapeutic products and platforms to address major unmet medical needs. We invest at all stages in a company’s evolution, from company creation through mid and late-stage clinical development. We are capable of leading or co-leading transactions, and employ a rigorous investment review process that distinguishes us and helps us with syndicate building and positioning companies well for a future public offering or M&A event.